Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Isolation and Quantification of Uremic Toxin Precursor-Generating Gut Bacteria in Chronic Kidney Disease Patients
Tessa Gryp, Geert Huys, Marie Joossens, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 6, pp. 1986-1986
Open Access | Times Cited: 89

Showing 1-25 of 89 citing articles:

Indoxyl Sulfate, a Tubular Toxin, Contributes to the Development of Chronic Kidney Disease
Tong-Hong Cheng, Ming-Chieh Ma, Min-Tser Liao, et al.
Toxins (2020) Vol. 12, Iss. 11, pp. 684-684
Open Access | Times Cited: 70
Administration of Lactobacillus reuteri Combined with Clostridium butyricum Attenuates Cisplatin-Induced Renal Damage by Gut Microbiota Reconstitution, Increasing Butyric Acid Production, and Suppressing Renal Inflammation
Yu‐Ping Hsiao, Hsiao‐Ling Chen, Jen‐Ning Tsai, et al.
Nutrients (2021) Vol. 13, Iss. 8, pp. 2792-2792
Open Access | Times Cited: 68
Intestinal microbiota and diabetic kidney diseases: the Role of microbiota and derived metabolites inmodulation of renal inflammation and disease progression
Charlotte M. Mosterd, Mehmet Kanbay, Bert‐Jan H. van den Born, et al.
Best Practice & Research Clinical Endocrinology & Metabolism (2021) Vol. 35, Iss. 3, pp. 101484-101484
Open Access | Times Cited: 62
Gut Microbiota and Atherosclerosis—Focusing on the Plaque Stability
Xinyi Shen, Lihua Li, Zhen Sun, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 62
Evaluation of the Function of Probiotics, Emphasizing the Role of their Binding to the Intestinal Epithelium in the Stability and their Effects on the Immune System
Nahid Javanshir, Golsa Nayeb Ghanbar Hosseini, Mahdieh Sadeghi, et al.
Biological Procedures Online (2021) Vol. 23, Iss. 1
Open Access | Times Cited: 58
Gut microbiome studies in CKD: opportunities, pitfalls and therapeutic potential
Hubert Krukowski, Sophie Valkenburg, Avra-Melina Madella, et al.
Nature Reviews Nephrology (2022) Vol. 19, Iss. 2, pp. 87-101
Closed Access | Times Cited: 44
Homeostasis in the Gut Microbiota in Chronic Kidney Disease
Shruti Bhargava, Erik Merckelbach, Heidi Noels, et al.
Toxins (2022) Vol. 14, Iss. 10, pp. 648-648
Open Access | Times Cited: 42
Inflammation in Children with CKD Linked to Gut Dysbiosis and Metabolite Imbalance
Johannes Holle, Hendrik Bartolomaeus, Ulrike Löber, et al.
Journal of the American Society of Nephrology (2022) Vol. 33, Iss. 12, pp. 2259-2275
Closed Access | Times Cited: 38
Role of the Microbiome in Gut-Heart-Kidney Cross Talk
Griet Glorieux, Sanjay K. Nigám, Raymond Vanholder, et al.
Circulation Research (2023) Vol. 132, Iss. 8, pp. 1064-1083
Closed Access | Times Cited: 34
Gut microbiota dysbiosis in AKI to CKD transition
G.R. Saranya, Pragasam Viswanathan
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114447-114447
Open Access | Times Cited: 30
Gut Microbiota in Chronic Kidney Disease: From Composition to Modulation towards Better Outcomes—A Systematic Review
Luminița Voroneanu, Alexandru Burlacu, Crischentian Brinza, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 5, pp. 1948-1948
Open Access | Times Cited: 30
Exploring the Preventive and Therapeutic Mechanisms of Probiotics in Chronic Kidney Disease through the Gut–Kidney Axis
Hsiao-Wen Huang, Ming‐Ju Chen
Journal of Agricultural and Food Chemistry (2024) Vol. 72, Iss. 15, pp. 8347-8364
Open Access | Times Cited: 9
High interindividual variability of indoxyl sulfate production identified by an oral tryptophan challenge test
Ting‐Yun Lin, Wei‐Kai Wu, Ting‐Yun Lin
npj Biofilms and Microbiomes (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 1
Gut-Derived Metabolites and Their Role in Immune Dysfunction in Chronic Kidney Disease
Griet Glorieux, Tessa Gryp, Alessandra F. Perna
Toxins (2020) Vol. 12, Iss. 4, pp. 245-245
Open Access | Times Cited: 68
Effects of Fecal Microbiota Transplantation on Composition in Mice with CKD
Christophe Barba, Christophe O. Soulage, Gianvito Caggiano, et al.
Toxins (2020) Vol. 12, Iss. 12, pp. 741-741
Open Access | Times Cited: 57
The Role of Gut Microbiota and Microbiota-Related Serum Metabolites in the Progression of Diabetic Kidney Disease
Qing Zhang, Yanmei Zhang, Lu Zeng, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 44
The Effect of ß-Glucan Prebiotic on Kidney Function, Uremic Toxins and Gut Microbiome in Stage 3 to 5 Chronic Kidney Disease (CKD) Predialysis Participants: A Randomized Controlled Trial
Zarina Ebrahim, Sebastian Proost, Raúl Y. Tito, et al.
Nutrients (2022) Vol. 14, Iss. 4, pp. 805-805
Open Access | Times Cited: 37
What If Not All Metabolites from the Uremic Toxin Generating Pathways Are Toxic? A Hypothesis
Raymond Vanholder, Sanjay K. Nigám, Stéphane Burtey, et al.
Toxins (2022) Vol. 14, Iss. 3, pp. 221-221
Open Access | Times Cited: 35
Faecal Microbiota Transplantation and Chronic Kidney Disease
Ji Bian, Ann Liebert, Brian Bicknell, et al.
Nutrients (2022) Vol. 14, Iss. 12, pp. 2528-2528
Open Access | Times Cited: 34
Gut Microbiota as a Source of Uremic Toxins
Vasily A. Popkov, Anastasia A. Zharikova, Evgenia A. Demchenko, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 1, pp. 483-483
Open Access | Times Cited: 32
Microbial Tryptophan Metabolism Tunes Host Immunity, Metabolism, and Extraintestinal Disorders
Moyan Liu, Max Nieuwdorp, Willem M. de Vos, et al.
Metabolites (2022) Vol. 12, Iss. 9, pp. 834-834
Open Access | Times Cited: 32
Metagenome-wide analysis uncovers gut microbial signatures and implicates taxon-specific functions in end-stage renal disease
Pan Zhang, Xifan Wang, Shenghui Li, et al.
Genome biology (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 16
Association of Sarcopenia and Gut Microbiota Composition in Older Patients with Advanced Chronic Kidney Disease, Investigation of the Interactions with Uremic Toxins, Inflammation and Oxidative Stress
Elisabetta Margiotta, Lara Caldiroli, Maria Luisa Callegari, et al.
Toxins (2021) Vol. 13, Iss. 7, pp. 472-472
Open Access | Times Cited: 39
Enterorenal crosstalks in diabetic nephropathy and novel therapeutics targeting the gut microbiota
Yinhua Ni, Liujie Zheng, Sujie Nan, et al.
Acta Biochimica et Biophysica Sinica (2022) Vol. 54, Iss. 10, pp. 1406-1420
Open Access | Times Cited: 27
Uremic Toxin-Producing Bacteroides Species Prevail in the Gut Microbiota of Taiwanese CKD Patients: An Analysis Using the New Taiwan Microbiome Baseline
Subhashree Shivani, Cheng‐Yen Kao, Amrita Chattopadhyay, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 25
Page 1 - Next Page

Scroll to top